Amarin Corporation - AMRN Net Assets per Single Share

Graphic logo of Amarin Corporation plc (AMRN)

Amarin Corporation plc (AMRN) specializes in developing medications for cardiovascular protection. Historical price action reflects the current 21.30 metric, leveraging capacities in the US and Ireland, where biopharmaceutical production is strictly controlled. The brand's advantage lies in the prescription status of Vascepa, which effectively prevents strokes through purified EPA. However, the loss of patent protection has led to stagnant development and a temporary lull in updating the drug portfolio.

Accounting Value of a Share: Amarin Corporation (AMRN) for 07/04/2022 - 10/28/2026

amarincorp.com - analytical breakdowns and key metrics (AMRN)

- price and consensus price forecast:
Price Chart Amarin Corp|AMRN - Fair Value Consensus
- market capitalization data:
Market Value Amarin Corporation|AMRN - Business Value
- book capitalization data:
Book Value per Share Amarin|AMRN - Accounting Value of Company|Market Capitalization to Book Value Ratio amarincorp.com|AMRN - Company Assets
- debt and liquidity data:
Total Debt to Capital Amarin Corporation plc|AMRN - Long-Term Debt to Capital|Short-Term Debt to Equity Amarin|AMRN - Aggregate Debt Obligations|Debt to Book Value Amarin Corporation|AMRN - Amount of Long-Term Liabilities|Company Short-Term Debts Amarin
Initial company analysis:AMRN (Amarin Corp)
Manufactured products of Amarin

Book value per share reflects the amount of equity minus all liabilities, demonstrating the real value of an investor's stake based on verified assets. Analyzing the net asset value per share allows for an assessment of the fundamental stability of Amarin Corporation plc (AMRN), whose capitalization is supported by the development of the drug Vascepa through global distribution partnerships and marketing synergies.

Competitors of Amarin Corporation plc (AMRN)

Net Assets per Single Share Regeneron Inc. (REGN)|IRTC: Accounting Value of a Share|Net Assets per Single Share Lantheus Holdings, Inc.|mineralystx.com (MLYS) - Equity per Share|HTFL - Book Value per Share|Accounting Value of a Share Kestra Medical Technologies, Inc.|Esperion Therapeutics Inc - Book Value per Share|Net Asset Value per Share anteristech.com (AVR)|Book Value per Share TNYA (Tenaya Therapeutics, Inc.)|cvrx.com - Book Value per Share|Net Assets per Single Share Milestone Pharmaceuticals Inc. (MIST)|Cardiol Therapeutics (CRDL) - Accounting Value of a Share|BEAT - Accounting Value per Share|Tenax Therapeutics Inc (TENX) - Book Price of a Share|ADGM (Adagio Medical Holdings) - Book Value per Share|Book Value per Share BCDA|Net Assets per Single Share VTAK (Catheter Precision, Inc.)|Accounting Value per Share arcabio.com (ABIO)|Book Value per Share ACST (Acasti Pharma Inc.)|Aerovate Therapeutics, Inc - Book Value per Share|Net Assets per Single Share Verve (VERV)|WINT - Accounting Value of a Share